Cargando…
Predictors of intravenous amiodarone induced liver injury
BACKGROUND: Intravenous (IV) amiodarone may be associated with liver injury that may necessitate drug discontinuation. The prediction of amiodarone induced liver injury (AILI) and its severity may help careful patient monitoring or the choice of other measures alternative to amiodarone in high risk...
Autores principales: | Diab, O.A., Kamel, John, Abd-Elhamid, Ahmed Adel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Egyptian Society of Cardiology
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5839365/ https://www.ncbi.nlm.nih.gov/pubmed/29622954 http://dx.doi.org/10.1016/j.ehj.2016.05.001 |
Ejemplares similares
-
Pharmacokinetics and tolerability of intranasal or intravenous administration of nalbuphine in infants
por: Pfiffner, Miriam, et al.
Publicado: (2023) -
Successful treatment of amiodarone-induced hepatic injury with n-acetylcysteine: A case report
por: Alanli, Recep, et al.
Publicado: (2021) -
Acceptability of different oral formulations in infants and preschool children
por: van Riet-Nales, Diana A, et al.
Publicado: (2013) -
Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects
por: van Riet-Nales, Diana A, et al.
Publicado: (2016) -
Lack of a significant change in caffeine metabolism in underweight children as determined by the caffeine breath test
por: Oshikoya, K A, et al.
Publicado: (2015)